发明授权
US08278306B2 C-met protein kinase inhibitors 有权
C-met蛋白激酶抑制剂

C-met protein kinase inhibitors
摘要:
Described herein are compounds that are useful as ROCK inhibitors. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including cardiovascular, inflammatory, neurological, or proliferative diseases or disorders.
公开/授权文献
信息查询
0/0